How Immunocore Holdings plc stacks up

IMCR · against 588 other Healthcare companies listed in US-listed

Valuation

29/ 100

Below the middle of the pack.

Ranked #309 of 589 · scores higher than 47% of peers

Bars: peers in each 10-point band of the valuation score

4 peers with a valuation score of 20–29, including IMCR · Click a bar to see the companies

Why valuation scores 29?

Weighted metrics compared with all Healthcare companies.

Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.

less operating profit (EBITDA) for the company's total value: weaker than 68% of peers. EBITDA yield: 0.1% vs peer median 4.0%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -1.2% vs peer median 1.5%
Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -2.7% vs peer median 0.0%

Metric by metric

Position: dot = IMCR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	IMCR	Peer median	Better than	Weight
Earnings yieldHigher is better · 577 reported	-1.2%	-4.3%	61%	30%
EBITDA yieldHigher is better · 578 reported	0.1%	-0.8%	53%	50%
Free cash flow yieldHigher is better · 553 reported	-2.7%	-2.3%	48%	20%
Book yieldHigher is better · 587 reported	27.2%	25.9%	52%	Context only

Ranking by valuation score

Top 5 and the companies ranked around IMCR

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
303	Travere Therapeutics, Inc.TVTX · US-listed	4.7B USD	30	42
309	AngioDynamics, Inc.ANGO · US-listed	493M USD	29	38
309	Cerus CorporationCERS · US-listed	472M USD	29	33
309	Delcath Systems, Inc.DCTH · US-listed	500M USD	29	63
309	Immunocore Holdings plcIMCR · US-listed	1.5B USD	29	43
313	Ascentage Pharma Group InternatAAPG · US-listed	1.3B USD	8	15
313	AbCellera Biologics Inc.ABCL · US-listed	3.9B USD	8	47
313	Abeona Therapeutics Inc.ABEO · US-listed	243M USD	8	27
313	Absci CorporationABSI · US-listed	1.7B USD	8	23

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…